Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Clinical Impact of Epithelial-to-Mesenchymal Transition Regulating MicroRNAs in Pancreatic Ductal Adenocarcinoma.

Dhayat SA, Traeger MM, Rehkaemper J, Stroese AJ, Steinestel K, Wardelmann E, Kabar I, Senninger N.

Cancers (Basel). 2018 Sep 13;10(9). pii: E328. doi: 10.3390/cancers10090328.

2.

Portal Hypertensive Polyposis in Advanced Liver Cirrhosis: The Unknown Entity?

Kara D, Hüsing-Kabar A, Schmidt H, Grünewald I, Chandhok G, Maschmeier M, Kabar I.

Can J Gastroenterol Hepatol. 2018 Aug 1;2018:2182784. doi: 10.1155/2018/2182784. eCollection 2018.

3.

Digital single-operator cholangioscopy: a useful tool for selective guidewire placements across complex biliary strictures.

Bokemeyer A, Gross D, Brückner M, Nowacki T, Bettenworth D, Schmidt H, Heinzow H, Kabar I, Ullerich H, Lenze F.

Surg Endosc. 2018 Jul 13. doi: 10.1007/s00464-018-6334-6. [Epub ahead of print]

PMID:
30006839
4.

Acute allograft rejection in liver transplant recipients: Incidence, risk factors, treatment success, and impact on graft failure.

Dogan N, Hüsing-Kabar A, Schmidt HH, Cicinnati VR, Beckebaum S, Kabar I.

J Int Med Res. 2018 Sep;46(9):3979-3990. doi: 10.1177/0300060518785543. Epub 2018 Jul 12.

5.

The weekend effect in liver transplantation.

Becker F, Vogel T, Voß T, Mehdorn AS, Schütte-Nütgen K, Reuter S, Mohr A, Kabar I, Bormann E, Vowinkel T, Palmes D, Senninger N, Bahde R, Kebschull L.

PLoS One. 2018 May 24;13(5):e0198035. doi: 10.1371/journal.pone.0198035. eCollection 2018.

6.

Risk factors for allograft failure in liver transplant recipients.

Huesing-Kabar A, Dohna CZ, Heinzow H, Cicinnati VR, Beckebaum S, Schmidt M, Gerth HU, Pohlen M, Wilms C, Palmes D, Schmidt HH, Kabar I.

Z Gastroenterol. 2018 Jul;56(7):745-751. doi: 10.1055/s-0043-125225. Epub 2018 Jan 16.

PMID:
29341040
7.

Single-operator cholangioscopy for biliary complications in liver transplant recipients.

Hüsing-Kabar A, Heinzow HS, Schmidt HH, Stenger C, Gerth HU, Pohlen M, Thölking G, Wilms C, Kabar I.

World J Gastroenterol. 2017 Jun 14;23(22):4064-4071. doi: 10.3748/wjg.v23.i22.4064.

8.

Molecular Adsorbent Recirculating System Can Reduce Short-Term Mortality Among Patients With Acute-on-Chronic Liver Failure-A Retrospective Analysis.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Hüsing-Kabar A, Wilms C, Maschmeier M, Kabar I, Torner J, Pavesi M, Arroyo V, Banares R, Schmidt HHJ.

Crit Care Med. 2017 Oct;45(10):1616-1624. doi: 10.1097/CCM.0000000000002562.

9.

Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study.

Gerth HU, Pohlen M, Thölking G, Pavenstädt H, Brand M, Wilms C, Hüsing-Kabar A, Görlich D, Kabar I, Schmidt HH.

PLoS One. 2017 Apr 12;12(4):e0175529. doi: 10.1371/journal.pone.0175529. eCollection 2017.

10.

Limits of and Complications after Embolization of the Hepatic Artery and Portal Vein to Induce Segmental Hypertrophy of the Liver: A Large Mini-Pig Study.

Heits N, Mueller L, Koops A, Koops S, Herrmann J, Hendricks A, Kabar I, Arlt A, Braun F, Becker T, Wilms C.

Eur Surg Res. 2016;57(3-4):155-170. Epub 2016 Jul 20.

PMID:
27434375
11.

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation.

Thölking G, Schmidt C, Koch R, Schuette-Nuetgen K, Pabst D, Wolters H, Kabar I, Hüsing A, Pavenstädt H, Reuter S, Suwelack B.

Sci Rep. 2016 Aug 30;6:32273. doi: 10.1038/srep32273.

12.

Successful Anti-HCV Therapy of a Former Intravenous Drug User with Sofosbuvir and Daclatasvir in a Peritranspant Setting: A Case Report.

Seifert LL, Heinzow H, Kabar I, Christensen S, Hüsing A, Schmidt HH.

Am J Case Rep. 2016 Aug 24;17:605-10.

13.

[Acute liver failure after ingestion of death cap mushrooms].

Zuliani AM, Kabar I, Mitchell T, Heinzow HS.

Dtsch Med Wochenschr. 2016 Jul;141(13):940-2. doi: 10.1055/s-0042-103987. Epub 2016 Jun 30. German.

PMID:
27359312
14.

[Long-term-management of organ transplant recipients].

Bürger C, Schmidt M, Maschmeier M, Stella J, Hüsing A, Wilms C, Schmidt HH, Kabar I.

Dtsch Med Wochenschr. 2016 Jul;141(13):927-32. doi: 10.1055/s-0042-103978. Epub 2016 Jun 30. Review. German.

PMID:
27359310
15.

Lipids in liver transplant recipients.

Hüsing A, Kabar I, Schmidt HH.

World J Gastroenterol. 2016 Mar 28;22(12):3315-24. doi: 10.3748/wjg.v22.i12.3315. Review.

16.

Tacrolimus Concentration/Dose Ratio is Associated with Renal Function After Liver Transplantation.

Thölking G, Siats L, Fortmann C, Koch R, Hüsing A, Cicinnati VR, Gerth HU, Wolters HH, Anthoni C, Pavenstädt H, Suwelack B, Schmidt HH, Kabar I.

Ann Transplant. 2016 Mar 22;21:167-79.

17.

Long-Term Renal Function in Liver Transplant Recipients After Conversion From Calcineurin Inhibitors to mTOR Inhibitors.

Hüsing A, Schmidt M, Beckebaum S, Cicinnati VR, Koch R, Thölking G, Stella J, Heinzow H, Schmidt HH, Kabar I.

Ann Transplant. 2015 Nov 26;20:707-13.

18.

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma.

Dhayat SA, Hüsing A, Senninger N, Schmidt HH, Haier J, Wolters H, Kabar I.

PLoS One. 2015 Oct 8;10(10):e0140066. doi: 10.1371/journal.pone.0140066. eCollection 2015.

19.

[Critically ill patients with decompensated liver cirrhosis - New aspects and intensive care management].

Maschmeier M, Hüsing A, Schmidt H, Kabar I.

Dtsch Med Wochenschr. 2015 Oct;140(20):1514-6. doi: 10.1055/s-0041-105973. Epub 2015 Oct 7. German.

PMID:
26445254
20.

Interferon-Free Sofosbuvir-Based Anti-HCV Therapy After Liver Transplantation.

Seifert LL, Vorona E, Bester C, Stahl M, Hüsing A, Beckebaum S, Kabar I, Heinzow H, Schmidt HH.

Ann Transplant. 2015 Sep 22;20:561-8. doi: 10.12659/AOT.893640.

Supplemental Content

Loading ...
Support Center